The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma.
Hyeong Dong YukMinyong KangEu Chang HwangJae Young ParkChang Wook JeongCheryn SongSeong Il SeoSeok-Soo ByunCheol KwakSung-Hoo HongJin-Soo ChungHakmin Leenull nullPublished in: Investigative and clinical urology (2020)
The PLR was an independent prognostic factor for survival outcomes in patients with mRCC. However, the association was statistically significant only in patients with clear cell type mRCC.